NCT00465803View on ClinicalTrials.gov

A Phase IIIb Study of DuoTrav to Treat Glaucoma or Ocular Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

January 31, 2009

Conditions
Open-angle GlaucomaOcular Hypertension
Interventions
DRUG

Travoprost 0.004%/timolol 0.5% ophthalmic solution

One drop in the study eye(s) once daily at either 8 AM or 8 PM for twelve months using the Dosing Aid

DRUG

Travoprost ophthalmic solution, 0.004%

One drop in the study eye(s) once daily at 8 PM for twelve months using the Dosing Aid

DRUG

Timolol maleate ophthalmic solution, 0.5%

One drop in the study eye(s) once daily at 8 AM or twelve months using the Dosing Aid

Trial Locations (1)

98104

Seattle, Seattle

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY